Literature DB >> 1712974

Low molecular weight angiogenesis factors.

R Odedra1, J B Weiss.   

Abstract

A number of substances have been proposed for the role of angiogenesis factors. Many of these are of protein origin and are therefore amenable to the tools of the molecular biologist. However a number of low molecular weight angiogenesis factors are emerging as important initiators and/or cofactors of neovascularization. Of these a number are known to stimulate angiogenesis indirectly, possibly through an inflammatory response. Some putative angiogenic factors stimulate microvessel endothelial cells nonspecifically, also causing migration and proliferation of large vessel cells. Others are specific for microvessel cells either for stimulating migration, proliferation or both. The nature and action of the low molecular weight factors in vivo and in vitro are reviewed.

Mesh:

Substances:

Year:  1991        PMID: 1712974     DOI: 10.1016/0163-7258(91)90025-h

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  6 in total

1.  Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis.

Authors:  B McLaughlin; J B Weiss
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

Review 2.  New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.

Authors:  S C Ballara; J M Miotla; E M Paleolog
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

3.  In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds.

Authors:  F X Maquart; G Bellon; B Chaqour; J Wegrowski; L M Patt; R E Trachy; J C Monboisse; F Chastang; P Birembaut; P Gillery
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

4.  Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis.

Authors:  Rodrigo Guabiraba; Remo C Russo; Amanda M Coelho; Mônica A N D Ferreira; Gabriel A O Lopes; Ariane K C Gomes; Silvia P Andrade; Luciola S Barcelos; Mauro M Teixeira
Journal:  Inflamm Res       Date:  2013-05-31       Impact factor: 4.575

5.  Factors involved in capillary growth in the heart.

Authors:  O Hudlická; M D Brown; H Walter; J B Weiss; A Bate
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

Review 6.  Tumour vasculature--a potential therapeutic target.

Authors:  C T Baillie; M C Winslet; N J Bradley
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.